FILE - In this May 11, 2021, file photo, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during hearing on Capitol Hill in Washington. The United States is devoting more than $3 billion to advance development of antiviral pills for COVID-19, according to an official briefed on the matter. The pills, which would be used to minimize symptoms after infection, are in development and could begin arriving by year’s end, pending the completion of clinical trials. (Jim Lo Scalzo/Pool Photo via AP, File)
WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics.